AMBS at the current share price is virtually risk free and could easily triple at any time. MNKD's share price could easily drop to below a dollar on April 2 and even if Arezza is approved still drop 40% as did AMRN, VVUS, and ARNA after their blockbuster drugs were approved.
You are correct. The F.D.A. did approve Exubera.
To be consistent I assume that the F.D.A. will require a cancer warning on Afrezza's label as it did with Exubera.
I wouldn't hold MNKD through the committee's vote. There's no compelling reason to approve Afrezza and a number of reasons not to.
"AMBS" - Amarantus Bioscience - Twitter: @AmarantusBio
Currently working with Becton Dickinson to develop diagnostic test to detect early stage Alzheimer's. Potential $500M annual market.
Company's patented drug, MANF, already has two orphan indications: Retinitis Pigmentosa and in the field of diabetes.
Read the Yahoo headline news.
AMBS will be one of the top performing stocks of 2014.
Zacks has a "BUY" rating on the stock. Get in under a dime and hold it for six months. Planned uplisting to the NASDAQ this year.
"AMBS" - Amarantus Bioscience -Most undervalued stock in the market. Under a dime. Working with Becton Dickinson developing diagnostic test to detect early stage Alzheimer's. Commecialization in 2014.
Company's patented drug, MANF, already has two orphan indication: one for Retinitis Pigmentosa and one in the field of diabetes.
Planned uplisting to the NASDAQ this year.
Over 13,000,000 shares sold short the last three sessions as the shorts try to keep the share price under a dime.
Imagine what happens to the share price when a partnership wit Becton Dickinson is announced. :)
The "Eve of Destruction".
The last three trading sessions to keep the price under a dime. That was without any news.
Imagine what happens when substantial news is released.
Happy New Year ahead for the AMBS shareholders. :)
Not surprising that there was profit taking today especially when there was no news.
The short volume yesterday was over 5,000,000 shares and I would imagine today's was comparable.
Over 13,000,000 shares traded today and it almost closed at .08 which is almost double what it was a few weeks ago.
The stock continues to be under accumulaion as word gets out to the market.
2014 will be a very good year for the AMBS shareholders.
As Ripley said, "Believe it or not?"
If he's correct the share price goes to .50.
Place your bets.
I know of three individual who shorted a total of over a million shares at .051. They covered at .062. Went long at .065 and are still holding their shares.